Hazlett, Burt & Watson’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7K Sell
756
-121
-14% -$1.11K ﹤0.01% 739
2026
Q1
$8K Hold
877
﹤0.01% 726
2025
Q4
$6K Hold
877
﹤0.01% 771
2025
Q3
$6K Sell
877
-230
-21% -$1.23K ﹤0.01% 724
2025
Q2
$7K Hold
1,107
﹤0.01% 638
2025
Q1
$10K Hold
1,107
﹤0.01% 572
2024
Q4
$12K Hold
1,107
0.01% 523
2024
Q3
$19K Hold
1,107
0.01% 470
2024
Q2
$18K Hold
1,107
0.01% 465
2024
Q1
$18K Sell
1,107
-101
-8% -$1.69K 0.01% 451
2023
Q4
$23K Sell
1,208
-101
-8% -$1.71K 0.02% 402
2023
Q3
$24K Hold
1,309
0.02% 390
2023
Q2
$29K Hold
1,309
0.02% 367
2023
Q1
$24K Hold
1,309
0.02% 366
2022
Q4
$22K Sell
1,309
-121
-8% -$1.72K 0.02% 376
2022
Q3
$21K Buy
+1,430
New +$28.8K 0.02% 368

Other funds holding NEOG

Hazlett, Burt & Watson's NEOG Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its Neogen (NEOG) stake by 14% in Q2 2026, selling an estimated $1.11K and leaving 756 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Hazlett, Burt & Watson first reported a position in NEOG in Q3 2022 and has held it in 16 quarters since. The position peaked at $29K in Q2 2023. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Hazlett, Burt & Watson held 756 shares of Neogen worth $7K as of Q2 2026.
  • Hazlett, Burt & Watson sold 121 Neogen shares in Q2 2026, an estimated $1.11K.
  • Neogen made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #739 holding.
  • Hazlett, Burt & Watson first reported a position in Neogen in Q3 2022 and has held it in 16 quarters since.
  • Hazlett, Burt & Watson's Neogen position peaked at $29K in Q2 2023.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.